Company / Revenue
Stoke Therapeutics, Inc. Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$184.4M
FY2025
5-year range
$8.8M / $184.4M
FY2022-FY2025
Trend
+2000.5%
vs FY2024
Sector context
#92 of 155
Health Care
What the data says
Revenue changed +2000% YoY in FY2025, a notable deviation from the 3-year average annual change of +657%.
Based on SEC 10-K filings.
$184M in FY2025 with a 3-year CAGR of +145.9%.
Improved from $12M to $184M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +145.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#92 of 155 in Health CareTop 59% of 155This company $184.4M Sector average $4.5B
▼
-95.9% below sector average
Key checks
Key Insights
- 3-year CAGR of +145.9%, indicating consistent growth.
- In FY2025, revenue increased 2000.5% year-over-year.
- Ranks #92 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $184.4M | +2000.5% |
| FY2024 | $8.8M | -29.2% |
| FY2023 | $12.4M | +0.0% |
| FY2022 | $12.4M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026